期刊文献+

S-甲酸谷胱甘肽水解酶与类风湿性关节炎的相关性

The correlation between S-formylglutathione hydrolase and rheumatoid arthritis
下载PDF
导出
摘要 目的检测类风湿性关节炎(rheumatoid arthritis,RA)早期和晚期患者血清中S-甲酸谷胱甘肽水解酶(Sformylglutathione hydrolase,Es D)水平,探讨Es D与RA的相关性及其诊断意义。方法以患者血清和正常人血清,采用二维凝胶电泳免疫印迹的比较寻找差异蛋白点,质谱测序和Western blot证明患者血清Es D在患者高表达、在正常人则检测不到。在此基础上,分别对早期、晚期、非RA患者(其它自身免疫性疾病)和正常人20例、40例、30例、40例血清通过ELISA的方法检测Es D水平,分析血清Es D水平与RA的相关性。结果 RA血清中的Es D水平明显高于非RA患者(P<0.001)和正常人(P<0.001),在早期和晚期RA中的敏感性分别为75%和72.5%,特异性为95%;进一步比较与RA现有诊断指标的相关性,发现Es D血清水平与ESR、CCP、DAS28评分具有显著相关性(P<0.05)而与RF无显著相关(P>0.05);与临床皮质激素治疗呈负相关。结论提示Es D血清水平对RA可能具有早期诊断价值;与激素治疗负相关说明该指标反映了疾病活动度;其在RA疾病发生及进展中的作用机理有待于进一步研究。 This study aimed to detect the serum level of S-formylglutathione hydrolase(Es D) in patients with early or late RA and probe into the relevance between Es D and RA, as well as to probe into its values in RA diagnosis. Two dimensional electrophoresis(2-DE) was utilized to seek differential protein points in the serum samples of patients and normal people, and then mass spectrometry and Western blot confirmed that the Es D was obviously higher expressed in the serum samples of RA patients but did not detectable in the serum samples of normal group. Based on this result, ELISA was used to detect the Es D level in serum of 20 early RA patients, 40 late RA patients, 30 non- RA patients(other auto-immune diseases) and 40 normal individuals, in order to analyze the relevance of serum Es D level with RA. Data showed that Es D level in RA serum was obviously higher than that of nonRA(P〈0.001) and normal groups(P〈0.001); the sensitivity of serum Es D level in early RA and late RA were 75% and72.5%, and the specificity was 95%. Furthermore, the level of serum Es D has obvious relevance with ESR, CCP and DAS28 score(P〉0.05), has no relevance with RF(P0.05), and has negative relevance with clinical corticosteroid therapy.In conclusion, this study indicated that serum Es D level perhaps has early diagnosis value for RA. The negative relevance of serum Es D level with corticosteroid therapy suggests that this marker reflects the disease activity; the role of Es D in the RA disease occurrence and development need more research.
出处 《免疫学杂志》 CAS CSCD 北大核心 2015年第11期978-982,共5页 Immunological Journal
基金 国家973计划(2010CB529102)
关键词 类风湿性关节炎 S-甲酸谷胱甘肽水解酶 差异蛋白组学 诊断标志 Rheumatoid arthritis S-formylglutathione hydrolase Differential proteomics Diagnostic marker
  • 相关文献

参考文献17

  • 1Firestein GS.Evolving concepts of rheumatoid arthritis[J].Nature,2003,423(6937):356-361.
  • 2傅德杰,王智勇.以Th17细胞为靶点治疗类风湿性关节炎研究进展[J].免疫学杂志,2011,27(9):812-815. 被引量:12
  • 3刘亢亢,汪庆童,黄蓓,张玲玲,魏伟.调节性B细胞的功能及在类风湿关节炎免疫反应中的作用[J].免疫学杂志,2013,29(9):800-803. 被引量:8
  • 4Suzuki A,Yamada R,Ohtake Yamanaka M,et al.Anti- citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis[J].Biochem Biophys Res Commun,2005,333(2):418-426.
  • 5Van Steendam K,Tilleman K,De Ceuleneer M,et al.Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins[J].Arthritis Res Ther,2010,12(4):R132.
  • 6Galati S,Beauvillain C,Renier G,et al.Comparison and relevance of rheumatoid factors,antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis[J],Ann Biol Clin(Paris),2008,66(2):157-164.
  • 7Jouen F,Vittecoq O,Leguillou F,et al.Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis[J].Clin Exp Immunol,2004,137(3):606-611.
  • 8Niewld TB,Harrison MJ,Paget SA.Anti-CCP antibody testing asadiagnostic and prognostic tool in rheumatoid arthritis[J].QJM,2007,100(4):193-201.
  • 9Song YW,Kang EH.Autoantibodies in rheumatoid arthritis:rheumatoid factors and anticitrullinated protein antibodies[J].QJM,2010,103(3):139-146.
  • 10Moeez S,John P,Bhatti A.Anti-citrullinated protein antibodies:role in pathogenesis of RA and potential as a diagnostic tool[J].Rheumatol Int,2013,33(7):1669-1673.

二级参考文献51

  • 1井申荣,邹全明.白细胞介素10的研究进展[J].免疫学杂志,2006,22(z1):26-28. 被引量:16
  • 2Dalwadi H, Wei B, Schrage M, et al. B cell developmental requirement for the G alpha i2 gene[J]. J Immunol, 2003, 170(4): 1707-1715.
  • 3Mizoguchi A, Bhan AK. A case for regulatory B cells [J]. J Immunol, 2006, 176(2): 705-710.
  • 4Vitale G, Mion F, Pucillo C. Regulatory B cells: evidence, developmental origin and population diversity [J]. Mol Immunol, 2010, 48(1/3): 1-8.
  • 5Jamin C, Morva A, Lemoine S, et al. Regulatory B lymphocytes in humans: a potential role in autoimmunity[J]. Arthritis Rheum, 2008, 58(7): 1900-1906.
  • 6Yanaba K, Bouaziz JD, Matsushita T, et al. The development and function of regulatory B cells expressing IL-10 (B10 ceLls)requires antigen receptor diversity and TLR signals[J]. J hnmunol, 2009, 182(12): 7459-7472.
  • 7Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells[J]. Ann Neurol, 2008, 64(2): 187-199.
  • 8Wilson MS, Taylor MD, O'gorman MT, et al. Helminth- induced CD19+CD23^hi B cells modulate experimental allergic and autoimmune inflammation [J]. Eur J Immunol, 2010, 40(6): 1682-1696.
  • 9Blair PA, Chavez Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-1ike B cells and for the suppression of lupus in MRL/lpr mice[J]. J Immunol, 2009, 182(6): 3492-3502.
  • 10Madan R, Demireik F, Surianarayanan S, et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation[J]. J Immunol, 2009, 183(4): 2312-2320.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部